Tedizolid Phosphate 200mg Tablet PCD Company in Delhi

Name: Tedizool Tablet (Tedizolid Phosphate (200mg) )
Brand: Tedizool 200 Tablet
Rating: 4.8 (150 reviews)

Tedizool 200mg Tablet Franchise Supplier in Rajasthan

Tedizolid 200mg Tablet Manufacturer in Himachal Pradesh

Best PCD Pharma for Tedizolid Tablets in Uttar Pradesh

Tedizolid Phosphate 200mg Third Party Manufacturer in Tamil Nadu

Tedizolid Tablets 200mg Exporter from India

Home/Products /tedizolid-phosphate-200mg

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Tedizolid 200mg Tablet Exporter & Supplier at Best Price

Tedizolid 200mg Tablet for Infections – Competitive Rates

Tedizolid Phosphate (200mg) – PCD Pharma Franchise Marketing Material

Tedizool Tablet – Tedizolid 200mg for Franchise & Exports

Tedizolid phosphate antibiotic tablet product literature PDF

Tedizool 200 Tablet

Composition : Tedizolid Phosphate (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10x6

Price : ₹1/-

Contact For Business Query

Tedizool Tablet contains Tedizolid Phosphate 200mg, a next-generation oxazolidinone-class antibiotic that acts as a prodrug, converting in vivo to its active form, tedizolid, after oral administration. It exerts its antibacterial action by inhibiting protein synthesis through binding to the 23S ribosomal RNA of the 50S subunit of bacterial ribosomes. Tedizolid shows potent activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus species, and vancomycin-resistant Enterococci (VRE). With once-daily dosing and a favorable safety profile, it serves as a convenient oral treatment alternative to injectable antibiotics in skin and soft tissue infections.

About the Product

Common side effects include nausea, headache, diarrhea, dizziness, and vomiting. Serious but rare adverse effects may include myelosuppression, peripheral neuropathy, or optic neuropathy, especially with prolonged use. Tedizolid should be used with caution in patients with pre-existing hematologic disorders.

Tedizool Tablet is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive microorganisms, including drug-resistant strains such as MRSA and VRE.

Tedizool should only be taken under the supervision of a qualified healthcare professional. It is not intended for viral infections (e.g., flu, common cold). Prolonged or inappropriate use may lead to bacterial resistance. Blood counts should be monitored during extended therapy. Caution is advised in patients on serotonergic agents due to potential for serotonin syndrome.

Store below 25°C in a dry place, away from sunlight and moisture. Keep out of reach of children.